Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
00871
CAS Number:
7481-89-2
2',3'-didésoxycytidine
Purity:
≥ 99 % (HPLC)
Synonym(s):
ddC, Zalcitabine
Documents
$127.79 /100 mg
Taille
Request Bulk Quote
Informations sur le produit

2',3'-Dideoxycytidine is a nucleoside analog that plays a crucial role in antiviral and anticancer research. This compound is particularly significant in the development of therapies for HIV and other viral infections, as it inhibits viral replication by interfering with the synthesis of viral DNA. Its unique structure allows it to mimic natural nucleosides, making it an effective tool in molecular biology and pharmacology. Researchers have utilized 2',3'-Dideoxycytidine in various studies to explore its potential in combination therapies, enhancing the efficacy of existing antiviral treatments.

In addition to its applications in virology, 2',3'-Dideoxycytidine is also being investigated for its potential in cancer treatment, where it may help to inhibit the growth of certain tumor cells. Its ability to selectively target rapidly dividing cells makes it a candidate for further exploration in oncology. With its proven track record in research and development, 2',3'-Dideoxycytidine continues to be a valuable asset for scientists and industry professionals seeking innovative solutions in the fields of virology and cancer therapy.

Numéro CAS 
7481-89-2
Formule moléculaire
C9H13N3O3
Poids moléculaire 
211.2
Point de fusion 
217-218 °C
Informations générales
Numéro CAS 
7481-89-2
Formule moléculaire
C9H13N3O3
Poids moléculaire 
211.2
Point de fusion 
217-218 °C
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

2',3'-Dideoxycytidine is widely utilized in research focused on:

  • Antiviral Therapy: This compound is primarily used in the treatment of HIV, where it acts as a nucleoside reverse transcriptase inhibitor, helping to reduce viral load and improve patient outcomes.
  • Research in Cancer Treatment: It has shown potential in cancer research, particularly in studies targeting specific types of leukemia and lymphoma, by disrupting DNA synthesis in rapidly dividing cells.
  • Development of Antiviral Drugs: The compound serves as a crucial building block in the synthesis of new antiviral agents, aiding researchers in developing more effective treatments against various viral infections.
  • Studying Nucleic Acid Metabolism: It is used in laboratory settings to investigate the metabolism of nucleic acids, providing insights into cellular processes and the mechanisms of drug action.
  • Formulating Combination Therapies: Researchers explore its use in combination with other antiretroviral drugs to enhance efficacy and reduce the likelihood of resistance in viral infections.

Citations